NCT04177758View on ClinicalTrials.gov

Evaluating Vitamin D3 Supplement on Post-Op Outcomes

PHASE4CompletedINTERVENTIONAL

Enrollment

137

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

October 8, 2021

Study Completion Date

March 1, 2022

Conditions

Knee Osteoarthritis

Interventions

DRUG

Vitamin D

Patients randomized to the experimental arm of the study will receive 50,000IU of vitamin D3 following surgery and asked to take the medication orally following surgery.

DRUG

Control

Patients randomized to the control will receive a placebo

Trial Locations (1)

60612

Rush University medical Center, Chicago

All Listed Sponsors

lead

Rush University Medical Center

OTHER

NCT04177758 - Evaluating Vitamin D3 Supplement on Post-Op Outcomes | Biotech Hunter | Biotech Hunter